If you took Tylenol or another acetaminophen product while pregnant and your child was later diagnosed with autism or ADHD, you may qualify for compensation.
Lawsuits against Tylenol maker Kenvue allege that acetaminophen use during pregnancy can increase the risk of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in children, and that the company failed to warn of this risk.
The litigation had been largely shut down in 2023 after the presiding judge barred certain expert testimony, but a July 2026 appeals court ruling revived hundreds of cases and reopened the path toward trial.
Here's what happens after you reach out:
A short set of free eligibility questions about your situation — takes about two minutes.
Our network reviews your answers against current qualifying criteria and reaches out if you may qualify.
You decide whether to move forward. There's never a cost to check your eligibility.
The cases are consolidated in MDL No. 3043 in the Southern District of New York before Judge Denise Cote. On July 13, 2026, the U.S. Court of Appeals for the Second Circuit reversed Judge Cote's earlier ruling and revived more than 500 lawsuits, finding the lower court had improperly excluded expert testimony connecting prenatal acetaminophen use to ASD/ADHD. The reversal clears the way for these cases to move toward trial. Kenvue is reportedly still weighing its legal options in response.
The Second Circuit's July 2026 reversal reopened the federal litigation after it had been largely stalled since 2023, so new and existing claims are moving forward again. Deadlines still vary by state, so it's worth checking with an attorney about your specific timeline rather than assuming there's no rush.
A Texas judge rejected Kenvue's motion to dismiss Attorney General Ken Paxton's consumer-protection lawsuit over Tylenol's autism warnings — a separate legal track from the federal personal-injury MDL.
Read more →A December 2024 dismissal by a federal judge sidelined more than 500 Tylenol autism/ADHD lawsuits for over a year and a half. Here's what that ruling said and why it mattered.
Read more →The Second Circuit has reversed a ruling that gutted the federal Tylenol autism/ADHD litigation, reviving more than 500 cases. Here's what the decision means and what happens next.
Read more →Get updates on Tylenol autism/ADHD, plus other case types we cover.
We'll keep you updated on Tylenol autism/ADHD and other case types.